Invesco Health Care Fund Class A (GGHCX)

Fund Assets	1.21B
Expense Ratio	1.07%
Min. Investment	$1,000
Turnover	59.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 18, 2025

Previous Close	42.19
YTD Return	8.57%
1-Year Return	20.17%
5-Year Return	16.91%
52-Week Low	35.16
52-Week High	42.99
Beta (5Y)	0.61
Holdings	80
Inception Date	Aug 7, 1989

About GGHCX

Invesco Health Care Fund Class A is an actively managed mutual fund designed to provide long-term capital growth by investing primarily in equity securities of global health care companies. The fund targets firms recognized as industry leaders and innovators, focusing on those with strong management and competitive advantages. By maintaining a portfolio diversified across sub-sectors such as pharmaceuticals, biotechnology, medical equipment, managed health care, and life sciences tools, the fund captures the dynamic growth potential of the health care industry. With over 70 holdings and a weighted average market capitalization in the large-cap range, the fund includes notable positions in companies like Boston Scientific, Eli Lilly, Stryker, and AbbVie. It invests across all market capitalizations and geographic regions, though it is predominantly U.S.-focused, with selective international exposure. By allocating at least 80% of assets to health care-related securities, Invesco Health Care Fund Class A plays a significant role for investors seeking targeted exposure to advancements and growth trends in global health care markets.

• Fund Family: Invesco
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: GGHCX
• Share Class: Class A
• Index: S&P Composite 1500 Health Care TR

Performance

GGHCX had a total return of 20.17% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.06%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
GGHYX	Class Y	0.82%
GTHIX	Investor Class	1.07%
GTHRX	Class R	1.32%
GTHCX	Class C	1.82%

Top 10 Holdings

46.66% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.84%
Johnson & Johnson	JNJ	6.32%
UnitedHealth Group Incorporated	UNH	6.06%
Merck & Co., Inc.	MRK	4.18%
argenx SE	ARGX	3.99%
AbbVie Inc.	ABBV	3.96%
Gilead Sciences, Inc.	GILD	3.46%
AstraZeneca PLC	AZN	2.90%
BrightSpring Health Services, Inc.	BTSG	2.73%
Welltower Inc.	WELL	2.22%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 18, 2025	$2.2025	Dec 18, 2025
Dec 16, 2024	$1.8353	Dec 16, 2024
Dec 16, 2021	$9.9297	Dec 16, 2021
Dec 15, 2020	$0.4737	Dec 15, 2020
Dec 13, 2019	$1.4728	Dec 13, 2019
Dec 14, 2018	$2.9024	Dec 14, 2018

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error